Treatment of periodontal infections due to anaerobic bacteria with short-term treatment with metronidazole
- PMID: 6941975
- DOI: 10.1111/j.1600-051x.1981.tb02022.x
Treatment of periodontal infections due to anaerobic bacteria with short-term treatment with metronidazole
Abstract
In the present report, five selected periodontal patients were treated for 1 week with metronidazole. Two of the patients had their teeth scales and root-planed the week they received metronidazole. Prior to treatment, B. asaccharolyticus accounted for 41% of the cultivable isolates and the spirochetes averaged 29% of the microscopic count in plaque removed from each of four pockets per patient. The presence of these elevated proportions of periodontopathic bacteria combined with the presence of periodontal pockets and attachment loss suggested that the patients were in a state of an active infectious process involving primarily anaerobic bacteria. If this be the case, then antimicrobial therapy directed against these anaerobes wih metronidazole was indicated. The 1-week treatment with metronidazole significantly reduced the proportions of these organisms for up to 6 months after treatment. Coincident with these findings was an improvement in the clinical parameters, especially in those sites that initially had greater than 5 mm pocket or attachment loss. These sites showed a 2 mm or more reduction in pocket depth and an almost 2 mm gain in apparent attachment that was evident 6 months after treatment. The results obtained were in only five patients. However, the magnitude of improvement suggests that antimicrobial therapy directed against anaerobic organisms may be a valuable adjunct to periodontal therapy.
Similar articles
-
Metronidazole in periodontitis: reduced need for surgery.J Clin Periodontol. 1992 Feb;19(2):103-12. doi: 10.1111/j.1600-051x.1992.tb00448.x. J Clin Periodontol. 1992. PMID: 1602034 Clinical Trial.
-
Metronidazole in periodontitis. I. Clinical and bacteriological results after 15 to 30 weeks.J Periodontol. 1984 Jun;55(6):325-35. doi: 10.1902/jop.1984.55.6.325. J Periodontol. 1984. PMID: 6376759
-
The therapeutic use of antimicrobial agents in patients with periodontal disease.Scand J Infect Dis Suppl. 1985;46:106-14. Scand J Infect Dis Suppl. 1985. PMID: 3865349
-
[Antimicrobial approaches to periodontal therapy].J Dent Assoc Thai. 1990 Mar-Apr;40(2):83-91. J Dent Assoc Thai. 1990. PMID: 2074322 Review. Thai.
-
Pharmacological control of periodontal disease. II. Antimicrobial agents.J Dent. 1995 Feb;23(1):5-14. doi: 10.1016/0300-5712(95)90654-z. J Dent. 1995. PMID: 7876417 Review.
Cited by
-
Selective medium for the isolation of Bacteroides gingivalis.J Clin Microbiol. 1986 Mar;23(3):441-5. doi: 10.1128/jcm.23.3.441-445.1986. J Clin Microbiol. 1986. PMID: 3958141 Free PMC article.
-
Rapid identification of Bacteroides gingivalis.J Clin Microbiol. 1982 Feb;15(2):345-6. doi: 10.1128/jcm.15.2.345-346.1982. J Clin Microbiol. 1982. PMID: 7040453 Free PMC article.
-
API ZYM system for identification of Bacteroides spp., Capnocytophaga spp., and spirochetes of oral origin.J Clin Microbiol. 1982 Jan;15(1):97-102. doi: 10.1128/jcm.15.1.97-102.1982. J Clin Microbiol. 1982. PMID: 6764781 Free PMC article.
-
Vancomycin as a selective agent for isolation of Bacteroides species.J Clin Microbiol. 1983 Nov;18(5):1282-4. doi: 10.1128/jcm.18.5.1282-1284.1983. J Clin Microbiol. 1983. PMID: 6643677 Free PMC article.
-
RgpA-Kgp peptide-based immunogens provide protection against Porphyromonas gingivalis challenge in a murine lesion model.Infect Immun. 2000 Jul;68(7):4055-63. doi: 10.1128/IAI.68.7.4055-4063.2000. Infect Immun. 2000. PMID: 10858222 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources